Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Contraception
Mifepristone does not stimulate proteins associated with endometrial bleeding
December 16th, 2004
Mifepristone does not stimulate proteins associated with endometrial bleeding. "Mifepristone has been used for both medical termination of pregnancy and emergency contraception. Mifepristone may have both an antiovulatory activity and an antiproliferative effect on the endometrium. We have evaluated the effect of mifepristone on vascular endothelial growth factor (VEGF) and thrombospondin-1 (TSP-1) using Ishikawa cells in vitro," scientists in the United States report. "Mifepristone, progesterone and 17beta-estradiol at concentrations of 1.0, 0.1 and 0.01 mcM, were added to confluent cells and further cultured for additional 24 hours. Total RNA was...
Source: Women's Health Weekly (2004-12-16)
|
